Diagnosis and management of dementia in general practice

Australian Family Physician

Volumn 33, Issue 10, 2004, Pages 789-793

  Pond, Dimity ^a   Brodaty, Henry ^b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALGORITHM; ARTICLE; CASE REPORT; DEMENTIA; FEMALE; GENERAL PRACTICE; GERIATRIC ASSESSMENT; HUMAN;

AGED; AGED, 80 AND OVER; ALGORITHMS; CHOLINESTERASE INHIBITORS; DEMENTIA; FAMILY PRACTICE; FEMALE; GERIATRIC ASSESSMENT; HUMANS;

EID: 16544380582     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. De Carli C. Mild cognitive impairment: prevalence, prognosis, aetiology and treatment. Lancet Neurology 2003;2:15-21.
2. Berman K, Brodaty H. Vitamin E in Alzheimer's disease and other neurodegenerative disorders. CNS Drugs 2004; in press.
3. Tabet N, Birks J, Grimley Evans J. Vitamin E for Alzheimer's disease. Cochrane Database of Systematic Reviews 2000;4:CD002854.
4. Religa D, Winblad B. Therapeutic strategies for Alzheimer's disease based on new molecular mechanisms. Acta Neurobiologiae Experimentalis 2003;63:393-396.
5. Le Bars PL, Kieser M, Itil KZ. A 26 week analysis of a double blind, placebo controlled trial of the ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 2000;11:230-237.
6. Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2004;1:CD004395.
7. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002;359:1283-1290.